Healthy adults
Conditions
Interventions
Apply Sample to the face skin twice daily for 6 weeks.
Sponsors
Kao Corporation
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1_Panelists who are females, ages 18-45, Caucasians and African Americans. 2_Panelists who possess a sufficient amount of sebum. 3_Panelists who are willing to avoid sun exposure, tanning beds, sunless tanners, and skin lightening products until the study completes. 4_Panelists who agree to follow their typical daily routine and refrain from starting any new activities (e.g. swimming, tanning bed usage, exercising, sunbathing, etc.). 5_Panelists who are willing to use only the provided test products in place of their own personal facial cleansers, facial moisturizers, and facial pore strips for the duration of the study. 6_Panelists are allowed to continue using their own personal cosmetic/make-up items (foundation, eye-shadow, mascara, etc.). 7_Panelists who agree to refrain from the use of any their own personal cosmetic/make-up items, especially for sebum regulation, anti-bacterial, and anti-inflammation. 8_Panelists who agree to refrain from the use of any supplements, OTC or prescription medications, especially for sebum regulation, anti-bacterial, and anti-inflammation. 9_Panelists who are willing to wash their faces at the night before each lab visit and refrain from applying any facial moisturizers, facial products, or make-up on their faces prior to the lab visits. 10_Panelists who are willing to have photographs and measurements taken on their faces.
Exclusion criteria
Exclusion criteria: 1_Panelists who have a known allergy or sensitivity to any facial care product, facial moisturizer, facial cleanser, pore strip, or to any specific ingredient or fragrance used in these types of products. 2_Panelists having illnesses or diseases which in the opinion of the investigator, might interfere with the conduct of the study or the interpretation of results. Especially panelists with any skin irritation, skin condition (such as rosacea, eczema, atopic dermatitis, or psoriasis), or severe acne on their face. 3_Panelists who take OTC or prescription medications which, in the opinion of the investigator, might interfere with the conduct of the study or the interpretation of results. 4_Panelists who have used a topical antibiotic on their faces in the last two weeks. 5_Panelists under the care of a doctor or dermatologist taking prescription medication (topical or oral) for any facial skin issues. 6_Panelists who have started any type of estrogen or hormone therapy including birth control pills in the last four weeks and/or are planning to start them during the study. Panelists who are pregnant, planning to be pregnant, or breastfeeding 7_Panelists who have used pore strips on their faces in the last two weeks. 8_Panelists who have undergone chemical peeling on their faces in the last six months. 9_Panelists who have undergone laser therapy, or phototherapy on their faces in the last six months. 10_Panelists currently participating in, or scheduled to participate in, another facial study during the study period. 11_Panelists who work for, or have household members who work for, a manufacturer or advertiser of personal care products.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| valuation of the sebum content, the sebum composition, the gene expressions, the skin flora, the skin color and the dermatological assessment before the application of XXXXI and after the application of XXXXI for 4 and 6 weeks | — |
Countries
North America
Contacts
Public ContactArisa Katou
Kao Corporation R&D -Core Technology-Biological Science Research
Outcome results
None listed